Trials / Conditions / Inappropriate ADH Syndrome

Inappropriate ADH Syndrome

8 registered clinical trials studyying Inappropriate ADH Syndrome.

Status	Trial	Sponsor	Phase
Terminated	Urea for Chronic Hyponatremia NCT04588207	Helbert Rondon Berrios, MD, MS	Phase 2
Completed	Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DI NCT02729766	University Hospital, Basel, Switzerland	Phase 2 / Phase 3
Terminated	Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia NCT01227512	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3
Terminated	A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional NCT00728091	Sanofi	Phase 3
Completed	Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion NCT00264914	Sanofi	Phase 3
Completed	Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion NCT00264927	Sanofi	Phase 3
Completed	"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia NCT00201994	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3
Completed	"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia NCT00072683	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3